- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Besilesomab is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- V09HA03 Besilesomab · Diagnostic radiopharmaceuticals, subgroup V09H, subgroup V09HA
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII 538316W9ZUCAS 537694-98-7DrugBank DB13979Q1871058
All presentations
No presentations of Besilesomab are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Besilesomab available for export from India?
No presentation of Besilesomab is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Besilesomab authorised in the European Union?
Yes. Besilesomab has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Besilesomab need cold chain shipping?
No listed presentation of Besilesomab is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Besilesomab in?
Besilesomab is classified under ATC code V09HA03 (Besilesomab).
References
- Scintimun: European public assessment report (EPAR). European Medicines Agency. Retrieved 9 June 2026
Request Besilesomab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.